Equivalent SARS-CoV-2 viral loads between nasopharyngeal swab and saliva in symptomatic patients
Preprint
Abstract
COVID-19 is diagnosed by detecting SARS-CoV-2 by nasopharyngeal swab (NPS) using real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Emerging evidences have shown the utility of saliva, although conflicting results have been reported regarding viral loads between NPS and saliva. We conducted a study to compare the viral loads in 42 patients with COVID-19. Both NPS and saliva specimens were simultaneously obtained at a median of 6 days (range, 1-12) after symptom onset. SARS-CoV-2 was detected in 34 (81%) using NPS (median Ct value [IQR]=27.4 [21.3, 35.6]) and 38 (90%) using saliva (median Ct value [IQR]= 28.9 [23.1, 33.6]). There was no significance difference between them (Wilcoxon signed rank test: P=0.79) and Kendall’s W was 0.82, showing a high degree of agreement, indicating equivalent viral loads in NPS and saliva. After symptom onset, the Ct values of both NPS and saliva continued to increase over time, with no substantial difference. Self-collected saliva has a detection sensitivity comparable to that of NPS and is a useful diagnostic tool with mitigating uncomfortable process and the risk of aerosol transmission to healthcare workers.Keywords
All Related Versions
- Published version: Scientific Reports, 11 (1), 1.
This publication has 10 references indexed in Scilit:
- Mass screening of asymptomatic persons for SARS-CoV-2 using salivamedRxiv, 2020
- Comparison of SARS-CoV-2 detection in nasopharyngeal swab and salivaJournal of Infection, 2020
- Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 TestingNew England Journal of Medicine, 2020
- Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2Journal of Clinical Microbiology, 2020
- Saliva is a reliable tool to detect SARS-CoV-2Journal of Infection, 2020
- Saliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community settingmedRxiv, 2020
- Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneouslyInternational Journal of Infectious Diseases, 2020
- Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabsmedRxiv, 2020
- Detection of SARS-CoV-2 in Different Types of Clinical SpecimensJAMA, 2020
- Consistent Detection of 2019 Novel Coronavirus in SalivaClinical Infectious Diseases, 2020